/VIVE
VIVE Stock - Viveve Medical, Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.12
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VIVE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.72
52W High$0.02
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $6.43M | $5.48M | $6.57M | $18.52M | $15.29M |
| Gross Profit | $620,000 | $296,000 | $1.02M | $7.32M | $7.44M |
| Gross Margin | 9.6% | 5.4% | 15.5% | 39.5% | 48.7% |
| Operating Income | $-21,553,000 | $-18,495,000 | $-29,937,000 | $-44,965,000 | $-33,730,000 |
| Net Income | $-22,027,000 | $-21,915,000 | $-42,526,000 | $-49,182,000 | $-36,630,000 |
| Net Margin | -342.8% | -400.0% | -647.6% | -265.6% | -239.6% |
| EPS | $-2.65 | $-16.56 | $-121.91 | $-1583.50 | $-2093.62 |
Company Overview
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VIVEBeat Rate
33%
Last 12 quarters
Avg Surprise
-106.6%
EPS vs Estimate
Beats / Misses
4/6
2 met exactly
Latest EPS
$-0.59
Q4 2022
EPS Surprise History
Q1 21
+28.6%
$-1.85vs$-2.59
Q2 21
-56.9%
$-0.80vs$-0.51
Q3 21
+24.6%
$-0.49vs$-0.65
Q4 21
-9.8%
$-0.67vs$-0.61
Q1 22
-22.0%
$-0.72vs$-0.59
Q2 22
0.0%
$-0.67vs$-0.67
Q3 22
0.0%
$-0.67vs$-0.67
Q4 22
+10.6%
$-0.59vs$-0.66
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 3, 2024 | — | — | — | — |
Q3 2024 | Sep 23, 2024 | — | — | — | — |
Q2 2024 | Jun 27, 2024 | — | — | — | — |
Q1 2024 | Feb 12, 2024 | — | — | — | — |
Q4 2023 | Nov 27, 2023 | — | — | — | — |
Q3 2023 | Sep 29, 2023 | — | — | — | — |
Q2 2023 | Jun 26, 2023 | — | — | — | — |
Q1 2023 | Mar 16, 2023 | $-0.62 | — | — | — |
Q4 2022 | Nov 10, 2022 | $-0.66 | $-0.59 | +10.6% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.67 | $-0.67 | 0.0% | = MET |
Q2 2022 | May 12, 2022 | $-0.67 | $-0.67 | 0.0% | = MET |
Q1 2022 | Mar 17, 2022 | $-0.59 | $-0.72 | -22.0% | ✗ MISS |
Q4 2021 | Nov 11, 2021 | $-0.61 | $-0.67 | -9.8% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-0.65 | $-0.49 | +24.6% | ✓ BEAT |
Q2 2021 | May 13, 2021 | $-0.51 | $-0.80 | -56.9% | ✗ MISS |
Q1 2021 | Mar 18, 2021 | $-2.59 | $-1.85 | +28.6% | ✓ BEAT |
Q4 2020 | Nov 12, 2020 | $-0.53 | $-2.60 | -390.6% | ✗ MISS |
Q3 2020 | Aug 13, 2020 | $-0.59 | $-4.40 | -645.8% | ✗ MISS |
Q2 2020 | May 14, 2020 | $-12.60 | $-8.20 | +34.9% | ✓ BEAT |
Q1 2020 | Mar 19, 2020 | $-12.40 | $-43.77 | -253.0% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about VIVE
What is VIVE's current stock price?
Viveve Medical, Inc. (VIVE) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for VIVE?
No analyst price targets are currently available for this stock.
What sector is Viveve Medical, Inc. in?
Viveve Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is VIVE's market cap?
Viveve Medical, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does VIVE pay dividends?
No, Viveve Medical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBXRXQ
Baudax Bio, Inc.
$0.00
Mkt Cap: $0.0B
KLDO
Kaleido Biosciences, Inc.
$0.00
Mkt Cap: $0.0B
LCDX
Caliber Imaging & Diagnostics, Inc.
$0.00
Mkt Cap: $0.0B
NMRD
Nemaura Medical Inc.
$0.00
Mkt Cap: $0.0B
SCIE
SpectraScience, Inc.
$0.00
Mkt Cap: $0.0B
SNDZ
Sunridge International, Inc.
$0.00
Mkt Cap: $0.0B
STBV
Strategic Global Investments, Inc.
$0.00
Mkt Cap: $0.0B
TNGNQ
Tengion, Inc.
$0.00
Mkt Cap: $0.0B
UPH
UpHealth, Inc.
$0.30
Mkt Cap: $0.0B
VICA
Rafina Innovations Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to VIVE for comparison